Literature DB >> 23295894

Economic benefits of inactivated influenza vaccines in the prevention of seasonal influenza in children.

Luis Salleras1, Encarna Navas, Nuria Torner, Andreu A Prat, Patricio Garrido, Núria Soldevila, Angela Domínguez.   

Abstract

The aim of this study was to systematically review published studies that evaluated the efficiency of inactivated influenza vaccination in preventing seasonal influenza in children. The vaccine evaluated was the influenza-inactivated vaccine in 10 studies and the virosomal inactivated vaccine in 3 studies. The results show that yearly vaccination of children with the inactivated influenza vaccine saves money from the societal and family perspectives but not from the public or private provider perspective. When vaccination does not save money, the cost-effectiveness ratios were very acceptable. It can be concluded, that inactivated influenza vaccination of children is a very efficient intervention.

Entities:  

Keywords:  cost-benefit; cost-effectiveness; cost-utility; economic evaluation; efficiency; influenza vaccination

Mesh:

Substances:

Year:  2013        PMID: 23295894      PMCID: PMC3891732          DOI: 10.4161/hv.23269

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  38 in total

1.  Economic impact of influenza vaccination in preschool children.

Authors:  G M Cohen; M D Nettleman
Journal:  Pediatrics       Date:  2000-11       Impact factor: 7.124

2.  Population-wide benefits of routine vaccination of children against influenza.

Authors:  Derek Weycker; John Edelsberg; M Elizabeth Halloran; Ira M Longini; Azhar Nizam; Vincent Ciuryla; Gerry Oster
Journal:  Vaccine       Date:  2005-01-26       Impact factor: 3.641

3.  Clinical and economic impact of influenza vaccination on healthy children aged 2-5 years.

Authors:  Susanna Esposito; Paola Marchisio; Samantha Bosis; Lara Lambertini; Laura Claut; Nadia Faelli; Ciro Bianchi; Giorgio L Colombo; Nicola Principi
Journal:  Vaccine       Date:  2005-08-25       Impact factor: 3.641

4.  Cost-effectiveness of adjuvanted influenza vaccination of healthy children 6 to 60 months of age.

Authors:  Monia Marchetti; Ursula M Kühnel; Giorgio L Colombo; Susanna Esposito; Nicola Principi
Journal:  Hum Vaccin       Date:  2007-01-29

5.  Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children.

Authors:  Kathleen M Neuzil; Lisa A Jackson; Jennifer Nelson; Alexander Klimov; Nancy Cox; Carolyn B Bridges; John Dunn; Frank DeStefano; David Shay
Journal:  J Infect Dis       Date:  2006-09-11       Impact factor: 5.226

6.  Live attenuated and inactivated influenza vaccine in school-age children.

Authors:  W C Gruber; L H Taber; W P Glezen; R D Clover; T D Abell; R W Demmler; R B Couch
Journal:  Am J Dis Child       Date:  1990-05

7.  Differences in national influenza vaccination policies across the European Union, Norway and Iceland 2008-2009.

Authors:  J Mereckiene; S Cotter; F D'Ancona; C Giambi; A Nicoll; D Levy-Bruhl; P L Lopalco; J T Weber; K Johansen; L Dematte; S Salmaso; P Stefanoff; D Greco; F Dorleans; A Polkowska; D O'Flanagan
Journal:  Euro Surveill       Date:  2010-11-04

8.  Cost-effectiveness of influenza vaccination of healthy children.

Authors:  Heini Salo; Terhi Kilpi; Harri Sintonen; Miika Linna; Ville Peltola; Terho Heikkinen
Journal:  Vaccine       Date:  2006-04-07       Impact factor: 3.641

9.  Oil-in-water emulsion adjuvant with influenza vaccine in young children.

Authors:  Timo Vesikari; Markus Knuf; Peter Wutzler; Aino Karvonen; Dorothee Kieninger-Baum; Heinz-Josef Schmitt; Frank Baehner; Astrid Borkowski; Theodore F Tsai; Ralf Clemens
Journal:  N Engl J Med       Date:  2011-10-13       Impact factor: 91.245

10.  Household-based costs and benefits of vaccinating healthy children in daycare against influenza virus: results from a pilot study.

Authors:  Maria Pisu; Martin I Meltzer; Eugene S Hurwitz; Michael Haber
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

View more
  1 in total

1.  Seasonal influenza vaccination in Kenya: an economic evaluation using dynamic transmission modelling.

Authors:  Jeanette Dawa; Gideon O Emukule; Edwine Barasa; Marc Alain Widdowson; Omu Anzala; Edwin van Leeuwen; Marc Baguelin; Sandra S Chaves; Rosalind M Eggo
Journal:  BMC Med       Date:  2020-08-20       Impact factor: 8.775

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.